Purpose: The aim was to evaluate central corneal thickness in patients with meibomian gland dysfunction.
Methods: The study group was made up of 40 eyes of 20 patients with meibomian gland dysfunction (mean age, 40.55 ± 10.7 years). Forty eyes of 20 healthy individuals (mean age, 39.25 ± 11.1 years) without any ophthalmic or systemic pathology were used as a control group. The central corneal thickness was measured with ultrasonic pachymetry.
Results: The mean central corneal thickness was 541.45 ± 24.68 µm in the study group and 544.30 ± 22.16 µm in the control group. There was no statistically significant difference in the mean central corneal thickness measurements in the meibomian gland dysfunction group in comparison with the control group (p > 0.05).
Conclusion: Central corneal thickness measurements do not differ in patients with meibomian gland dysfunction compared with healthy control subjects.
© 2011 The Authors. Clinical and Experimental Optometry © 2011 Optometrists Association Australia.